Outcome | IgG I and IgG II ≥1:64 (n= 12) | IgM II and IgG II ≥1:64 or IgM II ≥1:64 (n= 37) | No antibodies present (n= 1125) | χ2 test1 | |||
---|---|---|---|---|---|---|---|
 | n | (%) | n | (%) | n | (%) | P-value |
Perinatal mortality | |||||||
No | 12 | (100%) | 37 | (100%) | 1101 | (97.9%) | Â |
Yes | 0 | (0%) | 0 | (0%) | 24 | (2.1%) | 0.151 |
Apgar score | |||||||
<7 | 0 | (0%) | 1 | (2.7%) | 22 | (2.0%) | Â |
≥7 | 12 | (100%) | 36 | (97.3%) | 1079 | (98.0%) | 0.983 |
Missing | 0 | Â | 0 | Â | 24 | Â | Â |
Birth weight | |||||||
<2500 g | 2 | (16.7%) | 3 | (8.1%) | 86 | (7.8%) | Â |
≥2500 g | 10 | (83.3%) | 34 | (91.9%) | 1015 | (92.2%) | 0.544 |
Missing | 0 | Â | 0 | Â | 24 | Â | Â |
Birth weight by gestational age (<p10) | |||||||
No | 9 | (75.0%) | 35 | (94.6%) | 969 | (89.0%) | Â |
Yes | 3 | (25.0%) | 2 | (5.4%) | 120 | (11.0%) | 0.858 |
Missing | 0 | Â | 0 | Â | 36 | Â | Â |
Congenital malformations | |||||||
No | 12 | (100%) | 37 | (100%) | 1105 | (98.2%) | Â |
Yes | 0 | (0%) | 0 | (0%) | 20 | (1.8%) | 0.346 |
Gestational age | |||||||
<37 weeks | 1 | (8.3%) | 2 | (5.4%) | 109 | (10.0%) | Â |
≥37 weeks | 11 | (91.7%) | 35 | (94.6%) | 987 | (90.1%) | 0.378 |
Missing | 0 | Â | 0 | Â | 29 | Â | Â |
Any adverse outcome 2 | |||||||
No | 8 | (66.7%) | 32 | (86.5%) | 854 | (75.9%) | Â |
Yes | 4 | (33.3%) | 5 | (13.5%) | 271 | (24.1%) | 0.358 |